What NL-Lab does

NL-Lab is a Dutch medical research laboratory headquartered in Leeuwarden, Netherlands, established in 2019 as a subsidiary of Biotrack. It specializes in gut microbiome analysis, parasite screening, and intracellular pathogen detection, serving both individual consumers through a direct-to-consumer webshop and licensed healthcare practitioners (therapists, dieticians, integrative medicine doctors) through a dedicated PRO portal. The company operates within the functional and integrative medicine segment, positioning molecular diagnostics at a price point accessible outside hospital laboratories.

The core platform is C-FISH (Computerized Fluorescence In Situ Hybridization), a proprietary diagnostic technology developed by parent Biotrack. C-FISH is a CE-IVD registered in-vitro diagnostic system that uses molecular DNA probes to visualize specific microorganisms under fluorescence microscopy, then applies neural-network-based image analysis to identify and quantify microbial populations. The platform underpins a portfolio of tests including DARM (gut microbiome), PARA (parasites), INTRA (intracellular pathogens), Candida, H. pylori, omega-3 status, and emerging applications such as Mind & Microbiome.

NL-Lab's revenue model is built around per-test pricing and ancillary services. Consumer tests are priced between €65 and €215 and practitioner tests between €99 and €299, supplemented by training workshops and educational programs at approximately €115 per session. The company holds CE-IVD regulatory clearance for its diagnostic systems (Biotrack-MED and a COVID-19 analysis system, both registered in 2020) and is pursuing ISO 9001 certification. Commercial expansion is supported by a multilingual web presence in Dutch, English, and Italian, and by partnerships including a sports-performance program with AP-LAB and an R&D collaboration with KieN on the gut-brain axis.

Name

NL-Lab

Legal name

NL-Lab

Website

https://nl-lab.nl

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

NL-Lab is a Dutch medical research laboratory providing gut microbiome, parasite, and intracellular pathogen testing via its proprietary C-FISH diagnostic platform, serving consumers and licensed practitioners through a webshop and a dedicated PRO portal.

Ownership category

akta.pro rank

Product category

Microbiological Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD)

akta.pro secondary industries

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF)

Keywords

• Gut microbiome testing
• Parasite diagnostic testing
• Microbiological laboratory services
• Intracellular pathogen analysis
• C-FISH diagnostic technology

Headquarters

HQ city

Leeuwarden, Friesland

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Direct Consumer Test Sales: One-time sale of test kits to consumers through webshop. Consumers purchase gut health packages, parasite tests, and yeast/mold tests directly without practitioner involvement. Test kits include sample collection materials and shipping costs within Netherlands.
2. Practitioner PRO Account Testing: Subscription-free practitioner accounts enabling order of comprehensive PRO-line packages (PRO-Start, PRO-Expert, PRO-Master) and add-on tests (Mind & Microbiome, parasites, yeasts, gluten sensitivity). Practitioners order for themselves or clients; clients pay NL-Lab directly.
3. Corporate and Organization Services: Customized monitoring and screening programs for companies and organizations focusing on gut microbiome, tick-borne diseases, and employee health. B2B pricing through direct sales.
4. Training and Workshop Fees: Lab days and training courses (e.g., October 7, 2026 Lab day at €114.95 incl. VAT) offered at NL-Lab facility. Accredited training for MBOG practitioners.

Pricing tiers

Go-to-market motion4 records

Distribution channels5 records

Marketing channels7 records

Core offering

NL-Lab operates a private microbiological research laboratory specializing in gut microbiome analysis, parasite examination, yeast/mold testing, and intracellular pathogen detection using proprietary C-FISH (Computerized Fluorescence In Situ Hybridization) technology licensed from parent company Biotrack. The lab delivers dual-channel services: direct-to-consumer test kits sold through an online webshop and comprehensive PRO-line test packages ordered through a practitioner portal for healthcare professionals. All analyses use rRNA-based detection that measures both bacterial presence and activity rather than DNA-only detection methods.

Product overview

NL-Lab offers a dual-channel product portfolio: consumer-facing gut microbiome test kits available directly through their webshop, and professional practitioner packages accessible via the PRO portal. Consumer products include five themed symptom-oriented packages (Darm & Gewicht, Darm & Energie, Darm & Slaap, Darm & Huid, Darm & Haar) at €149 each, plus DarmBalans Compleet comprehensive test at €215. Practitioner offerings comprise three PRO-line tiers (PRO-Start at €99, PRO-Expert at €219, PRO-Master at €299) offering escalating depth from basic gut balance to complex dysbiosis analysis. Add-on modules include Mind & Microbiome neurotransmitter testing at €220 and gluten sensitivity analysis. Core diagnostic tests include the most comprehensive parasite test on the market (16 species, €125), yeast & mold testing (€65.50), and intracellular pathogens blood testing for practitioners. The entire portfolio is powered by proprietary C-FISH technology capable of measuring 100% of the gut microbiome including microbial activity—significantly exceeding PCR (60%) or culture methods (10%).

Differentiator

Problem solved

Functional benefit

Brands

• PRO-Line: Professional practitioner-focused product line including PRO-Start, PRO-Expert, and PRO-Master packages for gut microbiome analysis, along with add-on tests for parasites, yeasts, molds, gluten sensitivity, and Mind & Microbiome neurotransmitter testing.

Products and services

• Symptom-Oriented Gut Microbiome Packages (Gut & Weight, Gut & Energy, Gut & Sleep, Gut & Skin, Gut & Hair)

Quantifiable outcome

• Bacterial identification accuracy up to 96%
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• AP-LABcoreChannel Partner/ Reseller/ DistributorAP-LAB serves as the exclusive partner for NL-Lab's sports programs targeting top athletes and sports organizations. Athletes interested in NL-Lab's gut microbiome monitoring programs are directed to contact AP-LAB. AP-LAB collaborates with medical staff and athletes to implement customized monitoring programs.
• BiotrackcoreOEM/ Whitelabel/ Licensing PartnerBiotrack is the parent company and technology licensor of NL-Lab. Biotrack developed the C-FISH technology and Biotrack-MED analysis system. NL-Lab uses this patented technology developed by Biotrack for its laboratory analyses. Both companies are located at the same facility in Leeuwarden and operate globally with focus on Europe and United States.
• MBOG (Maatschappij ter Bevordering van Orthomoleculaire Geneeskunde)minorStrategic or Co-development PartnerMBOG is the Dutch association for orthomolecular medicine. NL-Lab's lab day training course is accredited by MBOG for continuing education of orthomolecular practitioners.
• KieN (GGZ Psychologen Praktijk)minorStrategic or Co-development PartnerKieN is a mental health psychology practice that collaborates with NL-Lab on the Mind & Microbiome research project, which received a grant for innovative diagnostics and treatment within mental healthcare.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• DayTwo: Microbiome-based personalized nutrition platform offering gut microbiome analysis with AI-driven dietary recommendations. Comparable consumer-facing gut testing offering, though more nutrition-actionable and more enterprise/B2B focused.
• Genetic Analysis AS: Norwegian diagnostics company offering the GA-map microbiome testing platform for clinical and research use. Comparable as a B2B-focused microbiome testing/diagnostics provider serving clinicians and labs across Europe.
• Viome: US-based direct-to-consumer gut microbiome testing company offering personalized nutrition recommendations from stool samples. Directly comparable to NL-Lab's consumer-facing gut microbiome tests but operates at much larger scale with significant VC backing.
• CosmosID: US-based microbial genomics company offering NGS-based microbiome identification and characterization services for clinical, industrial, and research customers. Comparable in providing advanced molecular microbiome analysis with proprietary bioinformatics.
• Atlas Biomed: UK-based personal health platform offering gut microbiome and DNA testing directly to consumers across Europe. Direct competitor in DTC microbiome testing with similar European footprint to NL-Lab.
• Thryve (Ombre): Gut microbiome testing company offering at-home test kits with personalized probiotic recommendations. Comparable consumer-facing microbiome testing service targeting health-conscious consumers.

Regional players

• Medivere Diagnostik: German diagnostic laboratory offering a range of specialty stool and microbiome tests to practitioners. Comparable in offering practitioner-facing diagnostic testing in the DACH market — regional rather than direct competition.
• Biovis Diagnostik: German specialty diagnostic laboratory focused on stool-based microbiome, inflammatory, and chronic disease testing for practitioners and clinics. Comparable practitioner-facing diagnostic testing in a neighboring geography.

Emerging players

• Carbiotix: Swedish microbiome health company offering gut microbiome testing and soluble fiber prebiotic interventions. Comparable as a European microbiome testing provider, though more focused on therapeutic fiber supplementation.
• Enterome: France-based microbiome-focused biotech developing diagnostics and therapeutics based on gut microbiome science. Overlapping technology platform and microbiome focus, though Enterome is more therapeutics-oriented.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/nl-lab

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NL-Lab